Innovations in Orally Disintegrating Tablets for Pediatric Drug Delivery
Summary: Ever since regulatory agencies globally mandate pediatric clinical trials for drugs intended for pediatric use, there has been a significant increase in the number of industrially sponsored pediatric clinical trials in recent years. However, pediatric drug delivery presents a unique set of challenges due to the varying physiological and developmental factors in children. Orally disintegrating tablets (ODTs) have emerged as a promising drug delivery solution to enhance medication adherence for pediatric patients due to their ease of administration, eliminating the need for water and reducing the risk of choking. This webinar explores the world of pediatric dosage forms and how ODTs are emerging as a specialized drug delivery system for children, focusing on the challenges, innovations, and considerations that shape their development.